Cellspan bronchial implant (Biostage)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCellspan bronchial implant (Biostage)

Drug Alias Nameautologous adipose-derived mesenchymal stem cells seeded onto bronchus support (Biostage)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy

Mechanisms of ActionStem cells stimulants

TargetsUpdating

Therapy Area/IndicationsLung InjuryBronchial Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHarvard Apparatus Regenerative Technology Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHarvard Apparatus Regenerative Technology Inc

Active IndicationsN/A

Inactive IndicationsLung InjuryBronchial Diseases

Other Information

ATC CodeN/A